A contemporary review of Clostridioides difficile infections in patients with haematologic diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A contemporary review of
Clostridioides difficile
infections in patients with haematologic diseases
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-25
DOI
10.1111/joim.13173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey
- (2020) Anke Verlinden et al. BONE MARROW TRANSPLANTATION
- The Network of Colonic Host Defense Peptides as an Innate Immune Defense Against Enteropathogenic Bacteria
- (2020) Graham A. D. Blyth et al. Frontiers in Immunology
- De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia
- (2020) Lindsey Rearigh et al. ANNALS OF HEMATOLOGY
- High incidence of healthcare facility‐acquired Clostridium difficile infections in chronic opioid users
- (2020) Michael Lichtbroun et al. JOURNAL OF INTERNAL MEDICINE
- Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers
- (2019) Nielson T. Baxter et al. mBio
- Low Incidence of Hospital-Onset Clostridium difficile Infection in Sickle Cell Disease
- (2019) Jibran Ahmed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection
- (2019) Mai-Chi N. Tran et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Antibiotic Prescribing and Respiratory Viral Testing for Acute Upper Respiratory Infections Among Adult Patients at an Ambulatory Cancer Center
- (2019) Elizabeth M Krantz et al. CLINICAL INFECTIOUS DISEASES
- Intestinal injury and gut permeability in sickle cell disease
- (2019) Dibyendu Dutta et al. Journal of Translational Medicine
- Antimicrobial Stewardship in Cancer Patients: The Time is Now
- (2019) Samuel L. Aitken et al. Journal of the National Comprehensive Cancer Network
- Microbiome evolution during host aging
- (2019) Francisco Daniel Davila Aleman et al. PLoS Pathogens
- Clostridium Difficile Infection Among Hematopoietic Stem Cell Transplant Recipients and Subsequent Development of Graft-Versus-Host Disease
- (2019) Shanee Chung et al. BLOOD
- Flexible cobamide metabolism in Clostridioides (Clostridium) difficile 630 Δerm
- (2019) Amanda N. Shelton et al. JOURNAL OF BACTERIOLOGY
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Butyric Acid and Leucine Induce α-Defensin Secretion from Small Intestinal Paneth Cells
- (2019) Akiko Takakuwa et al. Nutrients
- Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia
- (2019) Matthew S. L. Lee et al. Transplant Infectious Disease
- Intestinal microbiome analysis revealed dysbiosis in sickle cell disease
- (2018) Seah H. Lim et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice
- (2018) Myreen E. Tomas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transient Osmotic Perturbation Causes Long-Term Alteration to the Gut Microbiota
- (2018) Carolina Tropini et al. CELL
- Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
- (2018) Erik R Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
- (2018) J Michael Miller et al. CLINICAL INFECTIOUS DISEASES
- New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases
- (2018) Jasmohan S. Bajaj et al. DIGESTIVE AND LIVER DISEASE
- Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model
- (2018) Fuyuan Wang et al. Scientific Reports
- Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model
- (2018) Andrew J. Hryckowian et al. Nature Microbiology
- Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics
- (2018) Daniela Weber et al. CLINICAL INFECTIOUS DISEASES
- Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients
- (2018) Alex Ganetsky et al. CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) Advances in Nutrition
- Uneven distribution of cobamide biosynthesis and dependence in bacteria predicted by comparative genomics
- (2018) Amanda N. Shelton et al. ISME Journal
- Cobalamin (Vitamin B12) Induced a Shift in Microbial Composition and Metabolic Activity in an in vitro Colon Simulation
- (2018) Yuanyuan Xu et al. Frontiers in Microbiology
- 1337. SYN-004 (Ribaxamase) Protects the Gut Microbiome of Patients Treated With Ceftriaxone From Disruption and Reduces the Emergence of Antimicrobial Resistance
- (2018) John Kokai-Kun et al. Open Forum Infectious Diseases
- SYN-004 (ribaxamase), an oral beta-lactamase, mitigates antibiotic-mediated dysbiosis in a porcine gut microbiome model
- (2017) S. Connelly et al. JOURNAL OF APPLIED MICROBIOLOGY
- Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
- (2017) Yeon Joo Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
- (2017) Richard J Vickers et al. LANCET INFECTIOUS DISEASES
- Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis
- (2017) David Baur et al. LANCET INFECTIOUS DISEASES
- Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials
- (2017) Paul Moayyedi et al. MEDICAL JOURNAL OF AUSTRALIA
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term taxonomic and functional divergence from donor bacterial strains following fecal microbiota transplantation in immunocompromised patients
- (2017) Eli L. Moss et al. PLoS One
- Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study
- (2017) Andrew I.T. Hebbard et al. SUPPORTIVE CARE IN CANCER
- Immunosuppressive Treatment Alters Gut Microbiota and Modified Gut Microbiota Affects Immune Status
- (2017) Zijian Zhang et al. TRANSPLANTATION
- The risk of Clostridium difficile infection in patients with pernicious anaemia: a retrospective cohort study using primary care database
- (2017) Fatmah Othman et al. United European Gastroenterology Journal
- Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
- (2017) Manuela Aguilar-Guisado et al. Lancet Haematology
- Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review
- (2017) Matthew Snyder et al. Open Forum Infectious Diseases
- SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study
- (2017) John Kokai-Kun et al. Open Forum Infectious Diseases
- Peri-transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant
- (2016) Aya Agha et al. AMERICAN JOURNAL OF HEMATOLOGY
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states
- (2016) Christopher Staley et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation
- (2016) D Weber et al. BONE MARROW TRANSPLANTATION
- Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis
- (2016) Vanessa Arriola et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Ridinilazole: a novel therapy for Clostridium difficile infection
- (2016) Richard J. Vickers et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Impact on toxin production and cell morphology inClostridium difficileby ridinilazole (SMT19969), a novel treatment forC. difficileinfection
- (2016) Eugénie Bassères et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection
- (2016) Sahil Khanna et al. JOURNAL OF INFECTIOUS DISEASES
- Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
- (2016) Nathan D Mathewson et al. NATURE IMMUNOLOGY
- Fecal microbiota transplantation for recurrentClostridium difficileinfection in hematopoietic stem cell transplant recipients
- (2016) B.J. Webb et al. Transplant Infectious Disease
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- Review article: the antimicrobial effects of rifaximin on the gut microbiota
- (2015) H. L. DuPont ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection
- (2015) Michael C. Abt et al. Cell Host & Microbe
- The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection
- (2015) Xingmin Sun et al. MOLECULAR IMMUNOLOGY
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile Infection
- (2015) Daniel A. Leffler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
- (2015) Glen P. Carter et al. mBio
- Toll-like receptor 4 contributes to the inhibitory effect of morphine on colonic motility in vitro and in vivo
- (2015) Aitak Farzi et al. Scientific Reports
- Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection
- (2015) Emily G. McDonald et al. JAMA Internal Medicine
- Host recognition of Clostridium difficile and the innate immune response
- (2014) Carrie A. Cowardin et al. ANAEROBE
- Clostridium Difficile Infection after Allogeneic Hematopoietic Stem Cell Transplant: Strain Diversity and Outcomes Associated with NAP1/027
- (2014) Mini Kamboj et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Fecal microbiota transplant after hematopoietic SCT: report of a successful case
- (2014) C G de Castro et al. BONE MARROW TRANSPLANTATION
- Human Gut Microbes Use Multiple Transporters to Distinguish Vitamin B12 Analogs and Compete in the Gut
- (2014) Patrick H. Degnan et al. Cell Host & Microbe
- Vitamin B 12 as a Modulator of Gut Microbial Ecology
- (2014) Patrick H. Degnan et al. Cell Metabolism
- Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis
- (2014) Leah M. Feazel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clostridium difficile and the microbiota
- (2014) Anna M. Seekatz et al. JOURNAL OF CLINICAL INVESTIGATION
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection
- (2014) John P. Hegarty et al. SURGERY
- Hematologic diseases: High risk ofClostridium difficileassociated diarrhea
- (2014) Tae-Geun Gweon WORLD JOURNAL OF GASTROENTEROLOGY
- Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
- (2014) Casey M. Theriot et al. Nature Communications
- Nontoxigenic Clostridium difficile Protects Hamsters against Challenge with Historic and Epidemic Strains of Toxigenic BI/NAP1/027 C. difficile
- (2013) Kristin J. Nagaro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality
- (2013) J. E. Levine et al. BLOOD
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment ofClostridium difficileinfections
- (2013) Melinda M Soriano et al. Expert Review of Anti-Infective Therapy
- Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
- (2013) V. C. Antharam et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Toxin-Producing Clostridium difficile Strains as Long-Term Gut Colonizers in Healthy Infants
- (2013) I. Adlerberth et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Morphine Induces Bacterial Translocation in Mice by Compromising Intestinal Barrier Function in a TLR-Dependent Manner
- (2013) Jingjing Meng et al. PLoS One
- Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
- (2012) Chun Shing Kwok et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
- (2012) Sailajah Janarthanan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clostridium difficile clinical isolates exhibit variable susceptibility and proteome alterations upon exposure to mammalian cationic antimicrobial peptides
- (2012) Rebecca McQuade et al. ANAEROBE
- Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome
- (2012) Lise Willems et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Changing Epidemiology of Clostridium difficile–Associated Disease during Stem Cell Transplantation
- (2012) Steven M. Trifilio et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of -defensins
- (2012) Y. Eriguchi et al. BLOOD
- A cautionary tale for probiotic use in hematopoietic SCT patients–Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT
- (2012) A Mehta et al. BONE MARROW TRANSPLANTATION
- Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients
- (2012) C. D. Alonso et al. CLINICAL INFECTIOUS DISEASES
- The antimicrobial peptide cathelicidin modulatesClostridium difficile-associated colitis and toxin A-mediated enteritis in mice
- (2012) Tressia C Hing et al. GUT
- Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae
- (2012) Angela E. Reeves et al. INFECTION AND IMMUNITY
- Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
- (2012) T. Thapa et al. JOURNAL OF BACTERIOLOGY
- Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation
- (2012) Robert R. Jenq et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fecal microbiota transplantation for fulminantClostridium difficileinfection in an allogeneic stem cell transplant patient
- (2012) K. Neemann et al. Transplant Infectious Disease
- The economic burden of Clostridium difficile
- (2011) S.M. McGlone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection
- (2011) Moïra Joëlle Talpaert et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota
- (2011) M. C. Rea et al. JOURNAL OF CLINICAL MICROBIOLOGY
- A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins
- (2011) Anthony Ryan et al. PLoS Pathogens
- Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of NosocomialClostridum difficile–Associated Disease
- (2010) Amee R. Manges et al. JOURNAL OF INFECTIOUS DISEASES
- Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients
- (2010) Lynne V McFarland WORLD JOURNAL OF GASTROENTEROLOGY
- Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections
- (2009) Lynne V. McFarland ANAEROBE
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Both Oral Metronidazole and Oral Vancomycin Promote Persistent Overgrowth of Vancomycin-Resistant Enterococci during Treatment of Clostridium difficile-Associated Disease
- (2008) W. N. Al-Nassir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Recognition and Diagnosis ofClostridium difficileInfection
- (2008) John G. Bartlett et al. CLINICAL INFECTIOUS DISEASES
- Human α-Defensins Inhibit Clostridium difficile Toxin B
- (2008) Torsten Giesemann et al. GASTROENTEROLOGY
- Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression
- (2008) C. Deneve et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Clostridium difficile— More Difficult Than Ever
- (2008) Ciarán P. Kelly et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now